These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28760220)

  • 1. Weight and type 2 diabetes: new recommendations.
    Gómez Huelgas R
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():17-21. PubMed ID: 28760220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of weight in the management of patients with type 2 diabetes mellitus: towards an adipocentric approach to diabetes.
    Gorgojo Martínez JJ
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():8-16. PubMed ID: 28760227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profile of patients with type 2 diabetes mellitus treated with sodium- glucose cotransporter-2 inhibitors and experience in real-world clinical practice in Spain.
    Cuatrecasas G; Goñi-Goicoechea F
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():30-34. PubMed ID: 28760223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Type 2 diabetes mellitus: new treatments].
    Ascaso JF
    Med Clin (Barc); 2014 Aug; 143(3):117-23. PubMed ID: 23937815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antihyperglycaemic therapy with cardiovascular benefit in patients with type 2 diabetes who require hospitalisation: A cross-sectional study.
    Ena J; Carretero-Gómez J; Zapatero-Gaviria A; Carrasco-Sánchez FJ; Del Romero-Sánchez M; González-Becerra C; Blazquez-Encinar JC; Iguzquiza-Pellejero MJ; de Escalante Yangüela B; Gómez-Huelgas R;
    Rev Clin Esp (Barc); 2021 Nov; 221(9):517-528. PubMed ID: 34752263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of newer antidiabetic drugs on cardiovascular prevention and heart failure.
    Rojas-Velázquez JM; Giralt-Herrera A; Leiva-Enríquez J; Leiva-Enríquez J
    Clin Investig Arterioscler; 2021; 33(6):314-322. PubMed ID: 33820673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positioning of sodium-glucose cotransporter-2 inhibitors in national and international guidelines.
    Morillas C
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():49-53. PubMed ID: 28760226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond glycemic control: treating the entire type 2 diabetes disorder.
    Brunton S
    Postgrad Med; 2009 Sep; 121(5):68-81. PubMed ID: 19820276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antihyperglycaemic therapy with cardiovascular benefit in patients with type 2 diabetes who require hospitalisation: A cross-sectional study.
    Ena J; Carretero-Gómez J; Zapatero-Gaviria A; Carrasco Sánchez FJ; Del Romero-Sánchez M; González-Becerra C; Blazquez-Encinar JC; Iguzquiza-Pellejero MJ; de Escalante Yangüela B; Gómez-Huelgas R; ;
    Rev Clin Esp; 2020 Apr; ():. PubMed ID: 32279949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
    Deacon CF; Mannucci E; Ahrén B
    Diabetes Obes Metab; 2012 Aug; 14(8):762-7. PubMed ID: 22471248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes.
    Ovalle F
    Clin Ther; 2011 Apr; 33(4):393-407. PubMed ID: 21635987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in Perspective.
    Thompson PL; Davis TME
    Clin Ther; 2017 May; 39(5):1012-1025. PubMed ID: 27863704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists.
    Ji Q
    Clin Ther; 2017 Jun; 39(6):1244-1264. PubMed ID: 28526416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of body weight on antidiabetic treatment and predictors of weight control under real-world conditions: a 2-year follow-up of DiaRegis cohort.
    Hartmann B; Bramlage P; Schneider S; Tschöpe D; Gitt AK
    Acta Diabetol; 2015 Dec; 52(6):1093-101. PubMed ID: 26239142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacological management of metabolic syndrome.
    Rask Larsen J; Dima L; Correll CU; Manu P
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):397-410. PubMed ID: 29345505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of anti-diabetic therapy on overweight/obesity and dyslipidemia: traditional hypoglycemic agents (metformin, sulfonylureas, thiazolidinediones) versus glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors].
    Fiorentino TV; Sesti G
    G Ital Cardiol (Rome); 2013 Dec; 14(12 Suppl):15-25. PubMed ID: 24362783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes.
    Cornell S
    J Clin Pharm Ther; 2012 Oct; 37(5):510-24. PubMed ID: 22436069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.